Awarding of the 2025 Prize
Excellence, innovation, and clinical impact: celebrating the 15th Premio Lorini at the award ceremony on October 29, 2026
The Scientific Technical Committee of the Fondazione Andrea e Libi Lorini, responsible for evaluating the submissions based on rigorous scientific criteria, selected two outstanding research projects from over 50 submissions, highlighting their innovative nature and high potential for rapid clinical application.
Based on these recommendations, the Board of Directors of the Fondazione Andrea e Libi Lorini decided to award the 15th Premio Lorini ex aequo to:
- Dr. Augusto Bleve for the study RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression published in Cancer Discovery in 2025 (10.1158/2159-8290.CD-24-0199)
- Dr. Silvia Dusi for the study Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer published in Immunity in 2024 (57, 1378–1393)
The Prize was presented on October 29, 2026, during a ceremony at Palazzo Bovara in Milan.
Avv. Francesco Bellini, President of the Fondazione Andrea e Libi Lorini, welcomed the attendees and reaffirmed the Foundation's mission: rewarding brilliant research conducted by young scientists in oncology and AIDS treatment every year.
The winning projects were briefly introduced by Prof. Andrea Balsari and Dr. Raffaella Giavazzi. Subsequently, Dr. Bleve and Dr. Dusi presented their key findings to the audience and officially received the Premio Lorini 2025 from the President.
During the evening, Prof. Stefano Zuffi captivated the guests with a presentation on the myth of Europa, the young maiden who shifted the center of gravity of history and culture from East to West.























